In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

From stock market jitters caused by the artificial intelligence (AI) model DeepSeek to Government announcements on the AI Opportunities Action Plan, it can seem that news about AI is everywhere.

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

‘While molecular biomarkers such as genetics have proved valuable in the management of many diseases, the dynamic information provided by many physiological biomarkers will complement, enhance and ...

Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...

Our policy briefings and explainers are part of our horizon-scanning programme to identify those novel technologies showing greatest promise for health research and care. Succinct and accessible, they ...

Chantal is a Senior Policy Analyst contributing to many of PHG foundations projects including B-CAST, polygenic scores and Innovative Science. As a senior analyst she supports the science team in ...

In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make ...

Recent developments – at national and international levels – in the regulation and governance of data, AI and medical devices are having significant impacts and potential impacts on the application of ...